Skip to main content
Full access
Communications and Updates
Published Online: 1 July 2011

Psychotherapy for the Treatment of Substance Abuse

Based on: edited by Galanter Marc, M.D., Kleber Herbert D., M.D. Washington, DC, American Psychiatric Publishing, 2011, 427 pp., $65.00.
Over the past 20 years, the psychotherapeutic treatment of patients with substance use disorders has been revolutionized as a result of rigorous research studies in which manualized psychotherapies that were developed specifically for this patient population have been tested for efficacy in randomized controlled trials. Psychotherapy for the Treatment of Substance Abuse, edited by two preeminent addiction psychiatrists, Marc Galanter, M.D., and Herbert D. Kleber, M.D., provides a review of many of these therapies in a compact volume adapted from the editors' superb textbook The American Psychiatric Publishing Textbook of Substance Abuse Treatment, Fourth Edition.
In this book, most of the key psychotherapies and other behavioral therapies that have been studied for the treatment of addicted patients are reviewed: motivational enhancement therapy, cognitive-behavioral therapy, contingency management, psychodynamic psychotherapy, network therapy, 12-step facilitation, family therapy, and group therapy. A separate chapter discusses Alcoholics Anonymous. The authorship list encompasses leaders in the field, including those who were critical in the genesis and study of the treatments they discuss.
Several introductory chapters precede the discussion of the different psychotherapies, reviewing topics such as assessment of the patient, testing to identify recent drug use, cross-cultural aspects of addiction therapy, and patient placement criteria. While these chapters do not discuss psychotherapy per se, they round out the book to make it a more broadly encompassing review of evaluation and treatment of individuals with substance use disorders.
One of the strengths of this book is its inclusion of case examples and practical tips within the context of a review of the empirical evidence establishing the efficacy of the treatment modality being discussed. This helps to make this volume appropriate for both clinicians and researchers. The book is also designed both for those who specialize in addiction and for general psychiatrists who, by virtue of the high prevalence rate of substance use disorders, see many of these patients in their practices.

Footnote

Book review accepted for publication February 2011.

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 755 - 756

History

Accepted: February 2011
Published online: 1 July 2011
Published in print: July 2011

Authors

Details

Roger D. Weiss, M.D.

Funding Information

Dr. Weiss has served as a consultant to Titan Pharmaceuticals and has received research support from Eli Lilly.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share